In the evolving landscape of biochemical research, the exploration of selective compounds remains a primary focus for laboratories worldwide. Among the substances frequently discussed in scientific communities is avanafil peptide. While often referenced in discussions surrounding pharmacological advancements, it is essential to distingu Avanafil | PDE5 inhibitor | 330784-47-9 ish between its role as a specialized research tool and its broader clinical applications.
Technical Overview and Mechanism
From a biochemical perspec Avanafilis considered first line therapy of erectile dysfunction. Sildenafil increases both the number and duration of erections in males with ED.Read more tive, Avanafil is a highly selective inhibitor of PDE5 (phosphodiesterase type 5). Researchers often categorize it as an orally active, potent, and selective phosphodiesterase-5 (PDE5) inhibitor, characterized by its rapid onset of action. In laboratory settings, the compound is studied for its ability to modulate the cGMP-specific phosphodiesterase type 5 (PDE5) enzyme, which is responsible for the degradation of cGMP in the c by B Puchalski·2013—The drug is characterized by the fast onset of action, higher selectivity, better efficacy and lower rates of side effects. It should be administered in dose of Read more orpus cavernosum.
When analyzing the chemical properties, Avanafil is a highly selective PDE5 inhibitor with an IC50 value often cited around 5.2 nM. Its high selectivity—often reported as >121-fold over other PDE isoforms—makes it an intriguing subject for those focusing on enzyme kinetics and signaling pathways. For those involved in procurement for research, entities like Peptide Pros provide high-purity variants, often ensuring at least 99% purity via HPLC analysis, which is critical for maintaining consistency in *in vitro* or *in vivo* models.
Research Applications and Entity Context
It is important to note that Avanafil is widely recognized in literature as a compound that is a drug that can be used as a treatment for male erectile dysfunction in approved clinical settings. However, in the con Avanafil 50mg/ml @ 30ml text of research chemicals, it is strictly classified as a tool for investigation.
Many researchers explore this substance because it is a fast-acting, highly selective PDE5 (phosphodiesterase-5) inhibitor compared to first-generation alternatives. As a PDE5 Inhibitor for the Treatment of Erectile Dysfunction, it functions by inhibiting the breakdown of cGMP, thereby sustaining the levels of this molecule in vascular tissues. This mechanism effectively enhances erectile function by facilitating smooth muscle relaxation and increasing blood flow.
Distinguishing Clinical Use from Research
While Avanafil is used to treat men who have erectile dysfunction in medical environments, it is vital to maintain a clear boundary regarding its research status.
* Avanafil: MedlinePlus Drug Information Clinical Status: It is a PDE5 inhibitor approved for erectile dysfunction by major regulatory bodies, often marketed under trade names like Stendra or Spedra.
* Research Status: When sourced from suppliers for laboratory use, it is intended for biochemical assays. It is a safe and efficacious alternative to older compounds in controlled studies, but it is not intended for personal consumption.
Comparative Analysis in Scientific Literature
In the broader scope of Peptides and research chemicals, analysts often compare Avanafil with other PDE5 inhibitors like Sildenafil or Tadalafil. The consensus in peer-reviewed literature suggests that Avanafil is considered first-line therapy of erectile dysfunction due to its favorable pharmacokinetic profile. It is a medication that increases blood flow to the penis and is often noted for a quicker onset compared to its predecessors.
When reviewing the data, one might notice that Avanafil inhibits the cGMP-specific phosphodiesterase type 5 (PDE5), which is the foundati Avanafil: MedlinePlus Drug Information onal mechanism for its efficacy. Whether one is looking at the 50mg/ml co Avanafilis a PDE5 inhibitor approved for erectile dysfunction by the FDA on April 27, 2012 [2] and by EMA on June 21, 2013.Read more ncentration or bulk powder, the goal remains the same: to utilize a high-purity compound to improve blood flow in the nether regions under controlled experimental conditions.
Avanafil Drug Information | Good Health by HimsFinal Considerations for Researchers
As with any specialized chemi AVANAFIL· overview · Substance Hierarchy · Chemical Structure · Chemical Moieties · Names and Synonyms · Codes - Classifications · Codes - Identifiers · Characteristic Read more cal, the reliability of the source is paramount. Whether you are looking to buy Avanafil 50mg from Peptide Pros or other reputable peptide vendors, always prioritize documentation such as Certificates of Analysis (CoA) confirming the 99% purity levels.
By understanding that Avanafil is a phosphodiesterase-5 (PDE5) inhibitor used in the treatment of erectile dysfunction and that it is commonly used for erectile dysfunction in medicinal chemistry, researchers can better appreciate the nuances of this molecule. Always ensure that the handling and storage of such compounds adhere strictly to laboratory safety protocols, as Avanafil is a medication that treats erectile dysfunction and requires appropriate handling and storage to maintain its chemical integrity.